-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Adial Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2025.
- Adial Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$1.59M, a 2.51% increase year-over-year.
- Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$6.92M, a 1.7% decline from 2023.
- Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$6.81M, a 39.1% increase from 2022.
- Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$11.2M, a 6.39% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)